Murali K Matta (Murali Matta)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 9

Top Topics

Respiratory Tract

Mass Spectrometry

High Performance Liquid Chromatography

Drug Administration

Top Venues

Clinical pharmacology and therapeutics

Antibiotics (Basel, Switzerland)

Nanomaterials (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Chongwoo Yu, Wenlei Jiang, Murali K Matta, Rong Wang, Sam Haidar, Hyeonglim Seo
Lessons learned from regulatory submissions involving endogenous therapeutic analyte bioanalysis. Bioanalysis (2023)
Morasa Sheikhy, Sarah J Schrieber, Qin Sun, Victoria Gershuny, Murali K Matta, Jane P F Bai, Xiulian Du, Giri Vegesna, Aanchal Shah, Kristin Prentice, Colleen Nalepinski, Issam Zineh, Yow-Ming C Wang, David G Strauss, Jeffry Florian
Considerations for Use of Pharmacodynamic Biomarkers to Support Biosimilar Development - (I) A Randomized Trial with PCSK9 Inhibitors. Clinical pharmacology and therapeutics (2022)
Paula L Hyland, Lakshmi Manasa S Chekka, Deepti P Samarth, Barry A Rosenzweig, Erica Decker, Esraa G Mohamed, Yan Guo, Murali K Matta, Qin Sun, William Wheeler, Carlos Sanabria, James L Weaver, Sarah J Schrieber, Jeffry Florian, Yow-Ming C Wang, David G Strauss
Evaluating the Utility of Proteomics for the Identification of Circulating Pharmacodynamic Biomarkers of IFNβ-1a Biologics. Clinical pharmacology and therapeutics (2022)
Jeffry Florian, Victoria Gershuny, Qin Sun, Sarah J Schrieber, Murali K Matta, Anthony Hazel, Morasa Sheikhy, James L Weaver, Paula L Hyland, Cheng-Hui Hsiao, Giri Vegesna, Ryan DePalma, Aanchal Shah, Kristin Prentice, Carlos Sanabria, Yow-Ming C Wang, David G Strauss
Considerations for Use of Pharmacodynamic Biomarkers to Support Biosimilar Development - (III) A Randomized Trial with Interferon Beta-1a Products. Clinical pharmacology and therapeutics (2022)
Victoria Gershuny, Qin Sun, Sarah J Schrieber, Murali K Matta, James L Weaver, Ping Ji, Morasa Sheikhy, Cheng-Hui Hsiao, Giri Vegesna, Aanchal Shah, Kristin Prentice, Jennifer Deering, Yow-Ming C Wang, David G Strauss, Jeffry Florian
Considerations for Use of Pharmacodynamic Biomarkers to Support Biosimilar Development - (II) A Randomized Trial with IL-5 Antagonists. Clinical pharmacology and therapeutics (2022)
Nageswara R Pilli, Suresh Narayanasamy, Lin Xu, Ashok Chockalingam, Katherine I Shea, Sharron Stewart, Rodney Rouse, Vikram Patel, Murali K Matta
A high-throughput bioanalytical assay to support pharmacokinetic interaction study of oxycodone and diazepam in Sprague Dawley rats. RSC advances 10 (2) (2020)
Ashok Chockalingam, Sharron Stewart, Lin Xu, Adarsh Gandhi, Murali K Matta, Vikram Patel, Leonard Sacks, Rodney Rouse
Evaluation of Immunocompetent Urinary Tract Infected Balb/C Mouse Model For the Study of Antibiotic Resistance Development Using Escherichia Coli CFT073 Infection. Antibiotics (Basel, Switzerland) 8 (4) (2019)
Junyi Li, Jeffry Florian, Elizabeth Campbell, Sarah J Schrieber, Jane P F Bai, James L Weaver, Paula L Hyland, Theingi M Thway, Murali K Matta, Rachana H Lankapalli, Suresh Narayanasamy, Jimena Dancy, Robbert Zusterzeel, Jessica Y Tyson, Kristin W Prentice, Kathryn C Jackson, Vikram Patel, Rodney L Rouse, Yow-Ming C Wang, David G Strauss
Advancing Biosimilar Development Using Pharmacodynamic Biomarkers in Clinical Pharmacology Studies. Clinical pharmacology and therapeutics 107 (1) (2019)
Murali K Matta, Christopher R Beekman, Adarsh Gandhi, Suresh Narayanasamy, Christopher D Thomas, Adil Mohammad, Sharron Stewart, Lin Xu, Ashok Chockalingam, Katherine Shea, Vikram Patel, Rodney Rouse
Determination of Non-Transferrin Bound Iron, Transferrin Bound Iron, Drug Bound Iron and Total Iron in Serum in a Rats after IV Administration of Sodium Ferric Gluconate Complex by Simple Ultrafiltration Inductively Coupled Plasma Mass Spectrometric Detection. Nanomaterials (Basel, Switzerland) 8 (2) (2018)